Cyplasin-SC Enters Next Phase of Efficacy Animal Testing

09-Oct-2007

In recent third party validated cell based laboratory tests, Cyplasin-SC(TM) has shown a unique toxicity to many tumor cells, including human melanoma cells. However normal human cells are not affected by Cyplasin-SC(TM) at concentrations used to kill the tumor cells. These positive validated results allowed the Company to take Cyplasin-SC(TM) into dosing experiments in animals. The first question that was answered: what is the highest tolerated dosage and is it safe? A contract research Organization, AURIGON Life Sciences, Tutzing, Germany, performed the dose ranging studies.

The experiments were devised such that other questions could also be answered: What is the highest dose of Cyplasin-SC(TM) to be tolerated when injected only once? What is the highest dose of Cyplasin-SC(TM) to be tolerated when injected repeatedly and what is the best time interval for the injections? What is the best mode of application either under the skin (subcutaneously), or into a vein (intravenously), or into the body cavity (intraperitoneally)? Positive results from these studies were obtained as all mice injected with Cyplasin-SC(TM) at concentrations toxic for the human melanoma cells survived and the results showed Cyplasin-SC(TM) was well tolerated by the organism. The best application form appears to be a subcutaneous application where Cyplasin-SC(TM) is injected under the skin.

Cyplasin-SC(TM) has demonstrated a selective ability to rapidly kill melanoma cancer cells while leaving normal non-cancerous cells untouched. Cyplasin is a protein originally discovered and isolated by Professor Petzelt from a marine organism, the sea hare (Aplysia punctata). The protein can now be manufactured as a recombinant protein which allows the company to develop the protein as a potential anticancer therapeutic product. Patents have been issued to the Company covering the Cyplasin protein.

Other news from the department research and development

More news from our other portals

So close that even
molecules turn red...